|Bid||10.70 x 800|
|Ask||10.75 x 900|
|Day's Range||10.69 - 10.73|
|52 Week Range||10.19 - 10.85|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
NEW YORK, June 20, 2019 /PRNewswire/ -- Health Sciences Acquisitions Corporation ("the Company") (HSACU), a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, today announced that holders of the Company's units may elect to separately trade the common stock and warrants included in its units commencing on or about June 21, 2019. The common stock and warrants will trade on the NASDAQ Capital Market ("NASDAQ") under the symbols HSAC and HSACW, respectively.
NEW YORK , May 10, 2019 /PRNewswire/ -- Chardan, a global investment bank, announced today that the firm acted as lead left joint book runner in the initial public offering of Health Sciences Acquisitions ...
NEW YORK, May 9, 2019 /PRNewswire/ -- Health Sciences Acquisitions Corporation (NASDAQ: HSACU, the "Company") announced today that it priced its initial public offering of 10,000,000 units at $10.00 per unit. The sponsor of the Company is Health Sciences Holdings, LLC, an affiliate of RTW Investments, LP. The units are expected to be listed on The NASDAQ Capital Market ("NASDAQ") and trade under the ticker symbol "HSACU" beginning tomorrow, May 10, 2019.